From Target identification to clinical testing – Flow Cytometry applications in Drug Development

27th May 2021
11:00 am - 11:45 am CEST
Presented by: Dr. Thorsten Rieling, OLS OMNI Life Science. Flow cytometry offers solutions throughout the whole drug development process from early stage to clinical studies. It involves the analysis of multiple characteristics of millions of cells from of single population to complex heterogeneous populations. Within our presentation we will guide you to the use of flow cytometry throughout the drug development process providing examples from toxicological assays and multiparametric screening in clinical studies. Additionally, we will focus on the technical requirements to provide a standardized flow cytometry workflow supporting GxP requirements in the lab.

    * You can change your preference or unsubscribe at any time with the links included in any of our emails, or by contacting us at info@ols-bio.de. We will treat your information with respect and in accordance with the legal data protection regulations and our privacy policy.

    Subscribe for our newsletter

    e-mail required
    By submitting my data and sending the registration, I agree to receive the newsletter ordered here by email. My data will not be disclosed to third parties. I can revoke this consent at any time. More detailed information in the Privacy Policy section
    OLS OMNI Life Science Your Partner in Cell Research
    Imprint | Privacy Policy | Terms and Conditions